Home Details
| Official Symbol of Gene | HLA-B |
| Species | Homo sapiens |
| Entrez Gene ID | 3106 |
| Official Full Name | major histocompatibility complex, class I, B |
| Also known as | AS; HLAB; B-4901 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000234745 MIM:142830; AllianceGenome:HGNC:4932 |
| Map Location | 6p21.33 |
| Variation Type | allele |
| refSNP ID | HLA-B7 |
| Detected Sample | blood |
| Sample Detail | Lymphocytes |
| Detected Method | N/A |
| Disease | MS |
| Disease subtype | N/A |
| Population | Caucasians |
| Sample Size | 56 Caucasian MS patients and 72 healthy control Caucasians |
| Pubmed ID | 1085490 |
| Year | 1976 |
| Title | Multiple sclerosis and high incidence of a B lymphocyte antigen |
| Risk Type | Disease risk |
| Main Result | Positive |
| Result | Therefore, the HLA-D locus is probably closely related to the locus that deter- mines the group 4 antigen. In contrast,HLA-B7 is almost completely included in the group 4 antigen among MS patients, but not among the normal population. |
| Mechanism/Pathway | The antiserums defining the five other B lymphocyte specificities reacted at a lower frequency to B cells from multiple sclerosis patients, showing that increased reactivity to group 4 antiserums was specific. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.